Executive Summary Mechanistic Target of Rapamycin (mTOR) Inhibitors Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the mechanistic target of rapamycin (mTOR) inhibitors market will grow at a CAGR of 3.5% during the forecast period of 2022 to 2029. The “rapamune” accounts for the largest product type segment in the mechanistic target...